Skip to main content

The miniaturised biological assay: constraints and limitations

  • Chapter
  • First Online:
Chemogenomics and Chemical Genetics
  • 1205 Accesses

Abstract

The aim of this chapter is to sensitise the reader to the precautions to take when miniaturising a screening assay and when interpreting the results.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • DREWS J. (2000) Drug discovery: a historical perspective. Science 287: 1960-1964

    Article  CAS  Google Scholar 

  • EGGELING C., BRAND L., ULLMANN D., JAGER S. (2003) Highly sensitive fluorescence detection technology currently available for HTS. Drug Discov. Today 8: 632-641

    Article  CAS  Google Scholar 

  • SEETHALA R., FERNANDES P.B. (2001) Handbook of drug screening. New York-Basel, Marcel Dekker inc.

    Book  Google Scholar 

  • FERNANDES P.B. (1998) Technological advances in high throughput screening. Curr. Opin. Chem. Biol. 2: 597-603

    Article  CAS  Google Scholar 

  • FOX S., WANG H., SOPCHAK L., FARR-JONES S. (2002) High throughput screening 2002: moving toward increased success rates. J. Biomol. Screen. 7: 313-316

    Article  Google Scholar 

  • GOPALAKRISHNAN S.M., MAMMEN B., SCHMIDT M., OTTERSTAETTER B., AMBERG W., WERNET W., KOFRON J.L., BURNS D.J., WARRIOR U. (2005) An offline-addition format for identifying GPCR modulators by screening 384-well mixed compounds in the FLIPR. J. Biomol. Screen. 10: 46-55

    Article  CAS  Google Scholar 

  • HAGGARTY S.J., MAYER T.U., MIYAMOTO D.T., FATHI R., KING R.W., MITCHISON T.J., SCHREIBER S.L. (2000) Dissecting cellular processes using small molecules: identification of colchicine-like, taxol-like and other small molecules that perturb mitosis. Chem. Biol. 7: 275-286

    Article  CAS  Google Scholar 

  • HERTZBERG R.P., POPE A.J. (2000) High throughput screening: new technology for the 21st century. Curr. Opin. Chem. Biol. 4: 445-451

    Article  CAS  Google Scholar 

  • HORROCKS C., HALSE R., SUZUKI R., SHEPHERD P.R. (2003) Human cell systems for drug discovery. Curr. Opin. Drug Discov. Dev. 6(4): 570-575.

    CAS  Google Scholar 

  • HUBERT C.L., SHERLING S.E., JOHNSTON P.A., STANCATO L.F. (2003) Data concordance from a comparison between filter binding and fluorescence polarization assay formats for identification of ROCK-II inhibitors. J. Biomol. Screen. 8: 399-409

    Article  CAS  Google Scholar 

  • JAGER S., BRAND L., EGGELING C. (2003) New fluorescence techniques for high-throughput drug discovery. Curr. Pharm. Biotechnol. 4: 463-76.

    Article  CAS  Google Scholar 

  • JOHNSTON P.A., JOHNSTON P.A. (2002) Cellular platforms for HTS: three case studies. Drug Discov. Today 7: 353-363

    Article  CAS  Google Scholar 

  • KEMP D.M., GEORGE S.E., KENT T.C., BUNGAY P.J., NAYLOR L.H. (2002) The effect of ICER on screening methods involving CRE-mediated reporter gene expression. J. Biomol. Screen. 7: 141-148

    Article  CAS  Google Scholar 

  • KNOCKAERT M., GREENGARD P., MEIJER L. (2002b) Pharmacological inhibitors of cyclin-dependent kinases. Trends Pharmacol. Sci. 23: 417-425

    Article  CAS  Google Scholar 

  • KNOCKAERT M., WIEKING K., SCHMITT S., LEOST M., GRANT K.M., MOTTRAM J.C., KUNICK C. MEIJER L. (2002a) Intracellular targets of paullones: identification following affinity purification on immobilized inhibitor. J. Biol. Chem. 277: 25493-25501

    Article  CAS  Google Scholar 

  • KNOCKAERT M., MEIJER L. (2002) Identifying in vivo targets of cyclin-dependent kinase inhibitors by affinity chromatography. Biochem. Pharmacol. 64: 819-25

    Article  CAS  Google Scholar 

  • MCGOVERN S.L., CASELLI E., GRIGORIEFF N., SHOICHET B.K. (2002) A common mechanism underlying promiscuous inhibition from virtual and high-throughput screening. J. Med. Chem. 45: 1712-1722

    Article  CAS  Google Scholar 

  • MOORE K., REES S. (2001) Cell-based versus isolated target screening: how lucky do you feel? J. Biomol. Screen. 6: 69-74

    CAS  Google Scholar 

  • REVAH F. (2002) La révolution du médicament: de 1040 à 10 molécules. Sciences et Vie 218: 18-27

    Google Scholar 

  • SILLS M.A., WEISS D., PHAM Q., SCHWEITZER R., WU X, WU J.J. (2002) Comparison of assay technologies for a tyrosine kinase assay generates different results in high throughput screening. J. Biomol. Screen. 7: 191-214

    Article  CAS  Google Scholar 

  • STOCKWELL B.R. (2000) Frontiers in chemical genetics. Trends Biotechnol. 18: 449-455

    Article  CAS  Google Scholar 

  • STOCKWELL B.R., HAGGARTY S.J., SCHREIBER S.L. (1999) High throughput screening of small molecules in miniaturized mammalian cell-based assays involving post-translational modifications. Chem. Biol. 6: 71-83

    Article  CAS  Google Scholar 

  • SULLIVAN E., TUCKER E.M., DALE I.L. (1999) Measurement of [Ca2+] using the Fluorometric Imaging Plate Reader (FLIPR). Methods Mol. Biol. 114: 125-133

    CAS  Google Scholar 

  • VON LEOPRECHTING A., KUMPF R., MENZEL S., REULLE D., GRIEBEL R., VALLER M.J., BUTTNER F.H. (2004) Miniaturization and validation of a high-throughput serine kinase assay using the AlphaScreen platform. J. Biomol. Screen. 9: 719-725

    Article  CAS  Google Scholar 

  • WILLIAMS C. (2004) cAMP detection methods in HTS: selecting the best from the rest. Nat. Rev. Drug Discov. 3: 125-135

    Article  CAS  Google Scholar 

  • WU G., YUAN Y., HODGE C.N. (2003) Determining appropriate substrate conversion for enzymatic assays in high-throughput screening. J. Biomol. Screen. 8: 694-700

    Article  CAS  Google Scholar 

  • YOUNG K.H., WANG Y., BENDER C., AJIT S., RAMIREZ F., GILBERT A., NIEUWENHUIJSEN B.W. (2004) Yeast-based screening for inhibitors of RGS proteins. Methods Enzymol. 389: 277-301

    Article  CAS  Google Scholar 

  • YOUNG K., LIN S., SUN L., LEE E., MODI M., HELLINGS S., HUSBANDS M., OZENBERGER B., FRANCO R. (1998) Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen. Nat. Biotechnol. 16: 946-950

    Article  CAS  Google Scholar 

  • ZHANG J.H., CHUNG T.D., OLDENBURG K.R. (1999) A simple statistical parameter for use in evaluation and validation of high throughput screening assays. J. Biomol. Screen. 4: 67-73

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Knibiehler, M. (2011). The miniaturised biological assay: constraints and limitations. In: MARECHAL, E., Roy, S., Lafanechère, L. (eds) Chemogenomics and Chemical Genetics. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-19615-7_3

Download citation

Publish with us

Policies and ethics